Cargando…

Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations

Due to frequent cardiorespiratory events (CREs) in response to the first routine immunization (rIM), current guidelines recommend readmitting and monitoring extremely preterm infants after the second rIM, though evidence on CREs in response to the second rIM is weak. In a prospective observational s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohnhorst, Bettina, Weidlich, Cornelia, Peter, Corinna, Böhne, Carolin, Kattner, Evelyn, Pirr, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402520/
https://www.ncbi.nlm.nih.gov/pubmed/34452034
http://dx.doi.org/10.3390/vaccines9080909
_version_ 1783745809526816768
author Bohnhorst, Bettina
Weidlich, Cornelia
Peter, Corinna
Böhne, Carolin
Kattner, Evelyn
Pirr, Sabine
author_facet Bohnhorst, Bettina
Weidlich, Cornelia
Peter, Corinna
Böhne, Carolin
Kattner, Evelyn
Pirr, Sabine
author_sort Bohnhorst, Bettina
collection PubMed
description Due to frequent cardiorespiratory events (CREs) in response to the first routine immunization (rIM), current guidelines recommend readmitting and monitoring extremely preterm infants after the second rIM, though evidence on CREs in response to the second rIM is weak. In a prospective observational study, preterm infants with an increase in CREs after the first rIM were monitored for CREs before and after the second rIM. Seventy-one infants with a median gestational age of 26.4 weeks and a median weight of 820 g at birth were investigated at a median postnatal age of 94 days. All but seven infants showed an increase in CREs after the second rIM. The frequency of hypoxemias (p < 0.0001), apneas (p = 0.0003) and cardiorespiratory events requiring tactile stimulation (CRE-ts) (p = 0.0034) increased significantly. The 25 infants (35%) presenting with CRE-ts were significantly more likely to have been continuously hospitalized since birth (p = 0.001) and to receive analeptic therapy at the first rIM (p = 0.002) or some kind of respiratory support at the first (p = 0.005) and second rIM (p < 0.0001). At a postmenstruational age of 43.5 weeks, CRE-ts ceased. Our data support the recommendation to monitor infants who fulfil the above-mentioned criteria during the second rIM up to a postmenstruational age of 44 weeks.
format Online
Article
Text
id pubmed-8402520
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84025202021-08-29 Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations Bohnhorst, Bettina Weidlich, Cornelia Peter, Corinna Böhne, Carolin Kattner, Evelyn Pirr, Sabine Vaccines (Basel) Article Due to frequent cardiorespiratory events (CREs) in response to the first routine immunization (rIM), current guidelines recommend readmitting and monitoring extremely preterm infants after the second rIM, though evidence on CREs in response to the second rIM is weak. In a prospective observational study, preterm infants with an increase in CREs after the first rIM were monitored for CREs before and after the second rIM. Seventy-one infants with a median gestational age of 26.4 weeks and a median weight of 820 g at birth were investigated at a median postnatal age of 94 days. All but seven infants showed an increase in CREs after the second rIM. The frequency of hypoxemias (p < 0.0001), apneas (p = 0.0003) and cardiorespiratory events requiring tactile stimulation (CRE-ts) (p = 0.0034) increased significantly. The 25 infants (35%) presenting with CRE-ts were significantly more likely to have been continuously hospitalized since birth (p = 0.001) and to receive analeptic therapy at the first rIM (p = 0.002) or some kind of respiratory support at the first (p = 0.005) and second rIM (p < 0.0001). At a postmenstruational age of 43.5 weeks, CRE-ts ceased. Our data support the recommendation to monitor infants who fulfil the above-mentioned criteria during the second rIM up to a postmenstruational age of 44 weeks. MDPI 2021-08-16 /pmc/articles/PMC8402520/ /pubmed/34452034 http://dx.doi.org/10.3390/vaccines9080909 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bohnhorst, Bettina
Weidlich, Cornelia
Peter, Corinna
Böhne, Carolin
Kattner, Evelyn
Pirr, Sabine
Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations
title Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations
title_full Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations
title_fullStr Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations
title_full_unstemmed Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations
title_short Cardiorespiratory Events Following the Second Routine Immunization in Preterm Infants: Risk Assessment and Monitoring Recommendations
title_sort cardiorespiratory events following the second routine immunization in preterm infants: risk assessment and monitoring recommendations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402520/
https://www.ncbi.nlm.nih.gov/pubmed/34452034
http://dx.doi.org/10.3390/vaccines9080909
work_keys_str_mv AT bohnhorstbettina cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations
AT weidlichcornelia cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations
AT petercorinna cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations
AT bohnecarolin cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations
AT kattnerevelyn cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations
AT pirrsabine cardiorespiratoryeventsfollowingthesecondroutineimmunizationinpreterminfantsriskassessmentandmonitoringrecommendations